Stay updated on ATH-1017 Treatment in Parkinson's Dementia Clinical Trial
Sign up to get notified when there's something new on the ATH-1017 Treatment in Parkinson's Dementia Clinical Trial page.

Latest updates to the ATH-1017 Treatment in Parkinson's Dementia Clinical Trial page
- Check3 days agoNo Change Detected
- Check10 days agoChange DetectedThe record history now includes a new revision entry v3.5.2, replacing v3.5.0, reflecting an update to the study record.SummaryDifference0.1%

- Check17 days agoNo Change Detected
- Check39 days agoChange DetectedAdded revision v3.5.0 and removed revision v3.4.3 from the history.SummaryDifference0.1%

- Check46 days agoChange DetectedThe revision history now lists v3.4.3 and removes v3.4.2, updating the visible revisions.SummaryDifference0.1%

- Check61 days agoChange DetectedLeonaBio is now listed as sponsor; Athira Pharma is no longer listed as sponsor.SummaryDifference0.2%

- Check75 days agoChange DetectedAdded Revision: v3.4.2; removed the government funding lapse notice and Revision: v3.4.1.SummaryDifference0.7%

- Check82 days agoChange DetectedAdded a new revision entry (v3.4.1) to the study record history and removed the previous revision (v3.4.0). Also added a site-wide notice about government funding lapse and the NIH Clinical Center's operating status.SummaryDifference0.7%

Stay in the know with updates to ATH-1017 Treatment in Parkinson's Dementia Clinical Trial
Enter your email address, and we'll notify you when there's something new on the ATH-1017 Treatment in Parkinson's Dementia Clinical Trial page.